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ObituaryAlan Hall (1952–2015)Alan HallAlan Hall was known throughout the
world as the founder of the Rho GTPase
signaling field, which has had a huge
impact on many areas of research, from
animal and plant development to cancer
progression. He sadly died suddenly of a
heart attack while out jogging in New
York City on May 3, 2015. He was 62
and seemed fit and well. He was very
active in his research, as well as in his
new role as Editor-in-Chief of the Journal
of Cell Biology.
Alan was born in Yorkshire in the UK in
1952. He studied chemistry at the Univer-
sity of Oxford, taking a few courses in
biochemistry. He started his PhD studies
there in chemistry but soon moved to
Boston with his PhD supervisor Jeremy
Knowles, graduating in 1977. Alan moved
back to the UK and then to Switzerland for
two short postdocs, during which he
learned the techniques of molecular
biology. He was recruited as a young
group leader to the Institute of Cancer
Research in London in 1981 by then Di-
rector, Robin Weiss. There, he started
working with Chris Marshall on a long
and productive collaboration. Together,
they discovered and cloned the third
Ras oncogene, N-Ras. They published a
series of highly influential papers charac-
terizing the biochemical properties and
cellular functions of N-Ras.
In the late 1980s, Alan turned his
attention to the Rho cDNAs that Chris
had obtained but were sitting untouched
in a freezer. Alan combined his chemistry,
biochemistry, molecular biology, and
newly developed cell biology skills to
study Rho family proteins. He published
his first paper on Rho, showing that Rho
induced cell shape changes, in 1990.
This opened up a whole new field of
research. When I arrived in his laboratory
in 1990, this was a field ripe for growth.
It was a really exciting time at the Institute
of Cancer Research. Chris Marshall’s
laboratory was identifying kinases down-
stream of Ras. Alan purified and charac-
terized the first RhoGAP and realized
that it had homology to a region of Bcr,
which is fused to Abl in leukemias. This
led to the identification of a huge family
of Rho GAPs. We worked together to
demonstrate that Rho and Rac wereessential for extracellular signals to
induce changes to the actin cytoskeleton
and to coordinate cell migration.
In 1993, Alan moved to the newly
formed MRC Laboratory of Molecular
Cell Biology (LMCB) at University College
London, which was started up by Colin
Hopkins. He took over as head of
the LMCB in 2001. Having convinced the
MRC to give a lot more money to the
LMCB, he hired excellent young group
leaders, increased the PhD program
size, and bought a top-class coffee ma-
chine. He created a strong and successful
institute and balanced this admirably with
a highly productive laboratory. At the
LMCB, he recruited andworkedwith a se-
ries of excellent postdocs. For example,
he worked with Kate Nobes to determine
the function of Cdc42 in inducing filopo-
dia, with Emmanuelle Caron to describe
the roles of Rho GTPases in different
types of phagocytosis, and with Sandrine
Etienne-Manneville to show how Cdc42
and the Par polarity complex regulated
polarized cell migration. Alan also wrote
a series of influential and insightful re-
views on Rho GTPase signaling with
members of his laboratory.
Alan’s talents were spotted by Memo-
rial Sloan-Kettering Cancer Center in
New York, and the London community
sadly bid him farewell in 2006, when he
moved to Sloan-Kettering as Chair of the
Cell Biology Program. He expanded the
cell biology program by recruiting several
excellent new team leaders, leaving aCell 1strong program behind him. Alan’s
research in New York focused on roles
of Rho GTPase signaling in epithelial po-
larity and collective cell migration. In a
recent paper, he moved for the first time
into in vivo studies on collective cell
migration. This promised to be the start
of a new area of research for him.
I first met Alan when I gave a short talk
as a PhD student, working on Ras, at a
meeting in the UK. Alan was chairing the
session, and he asked me questions at
the end that showed genuine interest in
my results, not just because he was the
session chair. This epitomized his char-
acter as a scientist—Alan touched so
many scientists’ lives by listening to
them and taking a real interest in their
results. At conferences, Alan went to
posters and talks, asked insightful and
constructive questions, and gave helpful
advice. Alan was always generous with
his time and with reagents, which he
shared freely.
As a group leader, Alan was an inspira-
tional mentor. He treated everyone in the
laboratory equally and gave his postdocs
the freedom to work on the projects they
wanted to—they brought in their own
model systems or chose their project
based on previous results from the labo-
ratory. Whatever the project, Alan sup-
ported us to achieve our best. He valued
our ideas and input into the projects.
This created a great atmosphere in the
lab, where everyone helped each other,
because nobody was in competition. He
has left a big lab family, many of whom
have gone on to be successful group
leaders. We have all been influenced by
his style of leadership: he was interested
in everybody and went through our re-
sults carefully and thoroughly, discussing
future experiments in a way that made
sure we felt we owned them.
Alanwas an editor for the Journal of Cell
Biology for 20 years. Anybody who had
their paper handled by Alanwill remember
his constructive and careful analysis of
the reviewers’ points, bringing out what
was important to address and indicating
what could politely be ignored. Alan’s
research eminence was recognized
through his elections as a member of the
European Molecular Biology Organization
in 1995 and as a Fellow of the Royal Soci-
ety in 1999. He won the Novartis Medal
(UK Biochemical Society) in 2005, the61, June 4, 2015 ª2015 Elsevier Inc. 1239
Louis Jeantet Prize for Medicine in 2006,
and the Canada Gairdner Prize in 2009.
The last time that I sawAlanwas at a cell
biology conference in Brazil, at which he
was in fine form.We discussed everything
from Rho mutations in gastric cancers to1240 Cell 161, June 4, 2015 ª2015 Elsevier Inour children’s career moves. Alan’s sud-
den and tragic death has taken away an
influential, generous, and kind leader in
the field of cell signaling and GTPases.
He leaves behind his wife Eileen, his
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